The new addition connects Spherix’s unique approach to syndicated research to a highly dynamic market, filling the white space for ophthalmology drug stakeholders
EXTON, Pa., November 11, 2021 / PRNewswire / – Spherix Global Insights is a recognized market information company offering independent coverage of select specialty markets. This week, the company officially cut the ribbon on their new franchise, Ophthalmology.
Unlike other companies that offer syndicated reports, Spherix derives useful insights from its frequent, commercially focused, primary market research, which is highly tailored to each customer’s unique needs. Possessing unsurpassed content expertise and collaborating with a network of highly committed specialists are essential elements that set Spherix apart in the business analytics and intelligence field.
After careful consideration and at the request of several stakeholders, Spherix now covers key indications in ophthalmology, including neovascular age-related macular degeneration, diabetic macular edema, diabetic retinopathy, and other emerging disease areas. This new coverage comes on the market at a particularly appropriate time, as a number of new products (including ophthalmology’s first biosimilar) are ready for commercialization in the short term.
Prior to the expansion, Spherix expanded a team of experts and performed due diligence of the market landscape to bring the same value that current customers know to future partnerships within the space. The company is proud to announce Chrystal Ferguson as Insights Lead of Ophthalmology (formerly Cross-Specialty Insights Director at Spherix), given her extensive background in the field of therapy and expertise in her previous role at Spherix.
“I am extremely excited to combine Spherix’s unique approach to market insight and panel of experts with my 10+ years of experience in the field of ophthalmology to give our customers the confidence to make clear decisions for their brands in a developing and dynamic market.“, Ferguson mentions.
A complete list of 2022 publications covered by Spherix’s ophthalmology suite can be found here, spanning our launch tracking, patient audit and market landscape services.
Learn more about our services here.
Click here to download the full release schedule for 2022.
About Spherix Global Insights
Spherix Global Insights is a hyper-focused market intelligence firm that leverages our own independent data and expertise to provide strategic guidance so that biopharmaceutical stakeholders make decisions with confidence. We specialize in selected markets for dermatology, gastroenterology, nephrology, neurology, ophthalmology and rheumatology.
All company, brand or product names in this document are trademarks of their respective owners.
For more information contact:
Chrystal Ferguson, Ophthalmology Insights Director
See original content for downloading multimedia: https://www.prnewswire.com/news-releases/fueled-by-growing-demand-spherix-global-insights-introduces-ophthalmology-to-expert-suite-of-independent- market -research-and-telligence-services-301422433.html
SOURCE Spherix Global Insights